Literature DB >> 17767146

Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients.

C C Zai, V De Luca, R W Hwang, A Voineskos, D J Müller, G Remington, J L Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17767146     DOI： 10.1038/sj.mp.4002023

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  24 in total

1.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

Review 2.  Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

Authors:  Jian-Ping Zhang; Anil K Malhotra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01       Impact factor: 4.481

3.  Risk for antipsychotic-induced extrapyramidal symptoms: influence of family history and genetic susceptibility.

Authors:  Meike Kasten; Norbert Brüggemann; Inke R König; Katja Doerry; Susanne Steinlechner; Liv Wenzel; Katja Lohmann; Christine Klein; Rebekka Lencer
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

Review 4.  Pharmacogenetics in psychiatry: are we ready for widespread clinical use?

Authors:  Maria J Arranz; Shitij Kapur
Journal:  Schizophr Bull       Date:  2008-08-27       Impact factor: 9.306

Review 5.  Pharmacogenetics of antipsychotics.

Authors:  Eva J Brandl; James L Kennedy; Daniel J Müller
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

Review 6.  Genetics of Common Antipsychotic-Induced Adverse Effects.

Authors:  Raymond R MacNeil; Daniel J Müller
Journal:  Mol Neuropsychiatry       Date:  2016-05-20

Review 7.  Pharmacogenetics of response to antipsychotics in patients with schizophrenia.

Authors:  Maria J Arranz; Margarita Rivera; Janet C Munro
Journal:  CNS Drugs       Date:  2011-11-01       Impact factor: 5.749

Review 8.  Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications.

Authors:  Kazunari Yoshida; Daniel J Müller
Journal:  Mol Neuropsychiatry       Date:  2018-09-26

9.  Genomewide association study of movement-related adverse antipsychotic effects.

Authors:  Karolina Aberg; Daniel E Adkins; József Bukszár; Bradley T Webb; Stanley N Caroff; Del D Miller; Jonathan Sebat; Scott Stroup; Ayman H Fanous; Vladimir I Vladimirov; Joseph L McClay; Jeffrey A Lieberman; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  Biol Psychiatry       Date:  2009-10-28       Impact factor: 13.382

10.  A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trial.

Authors:  Huei-Ting Tsai; Stanley N Caroff; Del D Miller; Joseph McEvoy; Jeffrey A Lieberman; Kari E North; T Scott Stroup; Patrick F Sullivan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.